Lv2
172 积分 2023-07-16 加入
TROP-2 in Solid Tumors: From Oncogenic Driver to Therapeutic Target with Antibody-Drug Conjugates
16天前
已完结
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
20天前
已完结
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
20天前
已完结
Understanding and Overcoming Antibody‐Drug Conjugate Resistance: Biological Mechanisms and Emerging Analytical Frameworks in Breast Cancer
3个月前
已完结
Navigating the Landscape of Resistance Mechanisms in Antibody–Drug Conjugates for Cancer Treatment
3个月前
已完结
Using Secretion to Solve a Solubility Problem: High-Yield Expression in Escherichia coli and Purification of the Bacterial Glycoamidase PNGase F
4个月前
已完结
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer
4个月前
已完结
Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance
4个月前
已完结
Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro
4个月前
已完结
Targeting the C-MET/HGF Signaling Pathway in Pancreatic Ductal Adenocarcinoma
10个月前
已完结
皖公网安备34019202002308
